Amgen, Inc.

NASDAQ: AMGN
$247.29
+$1.04 (+0.4%)
Closing price August 8, 2022

5 Hard-Hit Dow Stocks Have Monster Upside and Come With Great Dividends
These five outstanding blue chip stocks have been hit hard this year and are offering growth and income investors incredible entry points and some big and, most importantly, reliable dividends. They...
Lee Jackson
9 months ago

2 Large Cap Biotech Leaders Pay Big Dividends and Have Huge Upside Potential
While not suited for conservative income investors, these two top biotech stocks could have huge total return potential and offer investors with a touch more risk tolerance some very tempting entry...
Lee Jackson
9 months ago

Thursday's Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More
Thursday's top analyst upgrades and downgrades included Amgen, Biogen, Commscope, Lockheed Martin, Northrop Grumman, ONEOK, Plug Power and Roku.
Lee Jackson
10 months ago
Last Updated: 10 months ago

Tuesday's Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma
Tuesday’s top analyst upgrades and downgrades included Amgen, Cirrus Logic, Hain Celestial, Johnson & Johnson, Lam Research, Merck, Spotify Technology and Vertex Pharmaceuticals.
Chris Lange
11 months ago

6 Stocks Marjorie Taylor Greene Is Buying
24/7 Wall St. takes a look at Georgia Representative Marjorie Taylor Greene and what stock trades are going on around her.
Chris Lange
11 months ago
Last Updated: 11 months ago

Goldman Sachs Has 4 Tech and Biotech Stocks to Buy With Big-Time Growth Potential
With the first quarter soon coming to an end, now is the time to move from momentum to strong growth stocks. Goldman Sachs feels these four could offer extra strength in a pricey stock market.
Lee Jackson
1 year ago
Last Updated: 1 year ago

Amgen, Biogen, Gilead, Merck, Pfizer and More Health Care Earnings Coming This Week
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Chris Lange
1 year ago
Last Updated: 1 year ago

2021's Dogs of the Dow
The 2021 Dogs of the Dow are now known, and investors who may want to follow this investing strategy have got some thinking to do.
Paul Ausick
1 year ago

Top Analyst Upgrades and Downgrades: Amgen, Amphenol, Continental Resources, EOG, FedEx, IMAX, Splunk and More
Tuesday's top analyst upgrades and downgrades included Amgen, Amphenol, Continental Resources, EOG Resources, FedEx, IMAX and Splunk.
Lee Jackson
1 year ago
Last Updated: 1 year ago

Meet the Preliminary Dogs of the Dow for 2021
One popular investment strategy, known as the Dogs of the Dow, has performed better than last year. What's ahead for the dogs in 2021?
Paul Ausick
1 year ago

Which Big Biotechs Short Sellers Favor Now
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
1 year ago

Big Biotech Short Sellers Seek Cover
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Chris Lange
1 year ago

Top Analyst Upgrades and Downgrades: Amgen, Boeing, eBay, Etsy, Fastly, Fiverr, Ford, GE, Gilead, Pinterest, Six Flags and More
Thursday's top analyst upgrades and downgrades included Amgen, Boeing, eBay, Etsy, Fastly, Fiverr, Ford, General Electric, Gilead Sciences, Pinterest and Six Flags.
Jon C. Ogg
1 year ago
Last Updated: 1 year ago

These Two Major Biotechs Are Bouncing Back With Q3 Results
Amgen and Gilead released their most recent financial results after the closing bell on Wednesday.
Chris Lange
1 year ago

Major Biotechs Have Short Sellers Looking Both Ways
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
1 year ago